HLA-DRB1
0.180
GeneticVariation
group
GWASDB
A genome-wide integrative genomic study localizes genetic factors influencing antibodies against Epstein-Barr virus nuclear antigen 1 (EBNA-1).
23326239 2013
HLA-DQA1
0.110
GeneticVariation
group
GWASDB
A genome-wide integrative genomic study localizes genetic factors influencing antibodies against Epstein-Barr virus nuclear antigen 1 (EBNA-1).
23326239 2013
×
Entrez Id: 7918
Gene Symbol: GPANK1
GPANK1
0.100
GeneticVariation
group
GWASDB
A genome-wide integrative genomic study localizes genetic factors influencing antibodies against Epstein-Barr virus nuclear antigen 1 (EBNA-1).
23326239 2013
×
Entrez Id: 56244
Gene Symbol: BTNL2
BTNL2
0.100
GeneticVariation
group
GWASDB
A genome-wide integrative genomic study localizes genetic factors influencing antibodies against Epstein-Barr virus nuclear antigen 1 (EBNA-1).
23326239 2013
×
Entrez Id: 7916
Gene Symbol: PRRC2A
PRRC2A
0.100
GeneticVariation
group
GWASDB
A genome-wide integrative genomic study localizes genetic factors influencing antibodies against Epstein-Barr virus nuclear antigen 1 (EBNA-1).
23326239 2013
×
Entrez Id: 5089
Gene Symbol: PBX2
PBX2
0.100
GeneticVariation
group
GWASDB
A genome-wide integrative genomic study localizes genetic factors influencing antibodies against Epstein-Barr virus nuclear antigen 1 (EBNA-1).
23326239 2013
×
Entrez Id: 1589
Gene Symbol: CYP21A2
CYP21A2
0.100
GeneticVariation
group
GWASDB
A genome-wide integrative genomic study localizes genetic factors influencing antibodies against Epstein-Barr virus nuclear antigen 1 (EBNA-1).
23326239 2013
×
Entrez Id: 7917
Gene Symbol: BAG6
BAG6
0.100
GeneticVariation
group
GWASDB
A genome-wide integrative genomic study localizes genetic factors influencing antibodies against Epstein-Barr virus nuclear antigen 1 (EBNA-1).
23326239 2013
×
Entrez Id: 80741
Gene Symbol: LY6G5C
LY6G5C
0.100
GeneticVariation
group
GWASDB
A genome-wide integrative genomic study localizes genetic factors influencing antibodies against Epstein-Barr virus nuclear antigen 1 (EBNA-1).
23326239 2013
TSBP1-AS1
0.100
GeneticVariation
group
GWASDB
A genome-wide integrative genomic study localizes genetic factors influencing antibodies against Epstein-Barr virus nuclear antigen 1 (EBNA-1).
23326239 2013
EHMT2-AS1
0.100
GeneticVariation
group
GWASDB
A genome-wide integrative genomic study localizes genetic factors influencing antibodies against Epstein-Barr virus nuclear antigen 1 (EBNA-1).
23326239 2013
×
Entrez Id: 58496
Gene Symbol: LY6G5B
LY6G5B
0.100
GeneticVariation
group
GWASDB
A genome-wide integrative genomic study localizes genetic factors influencing antibodies against Epstein-Barr virus nuclear antigen 1 (EBNA-1).
23326239 2013
HLA-DQB1
0.100
GeneticVariation
group
GWASDB
A genome-wide integrative genomic study localizes genetic factors influencing antibodies against Epstein-Barr virus nuclear antigen 1 (EBNA-1).
23326239 2013
×
Entrez Id: 10919
Gene Symbol: EHMT2
EHMT2
0.100
GeneticVariation
group
GWASDB
A genome-wide integrative genomic study localizes genetic factors influencing antibodies against Epstein-Barr virus nuclear antigen 1 (EBNA-1).
23326239 2013
×
Entrez Id: 1460
Gene Symbol: CSNK2B
CSNK2B
0.100
GeneticVariation
group
GWASDB
A genome-wide integrative genomic study localizes genetic factors influencing antibodies against Epstein-Barr virus nuclear antigen 1 (EBNA-1).
23326239 2013
HLA-DRB9
0.100
GeneticVariation
group
GWASDB
A genome-wide integrative genomic study localizes genetic factors influencing antibodies against Epstein-Barr virus nuclear antigen 1 (EBNA-1).
23326239 2013
×
Entrez Id: 3122
Gene Symbol: HLA-DRA
HLA-DRA
0.100
GeneticVariation
group
GWASDB
A genome-wide integrative genomic study localizes genetic factors influencing antibodies against Epstein-Barr virus nuclear antigen 1 (EBNA-1).
23326239 2013
×
Entrez Id: 7157
Gene Symbol: TP53
TP53
0.100
AlteredExpression
group
LHGDN
Epstein Barr virus associated pediatric nasopharyngeal carcinoma: its correlation with p53 and bcl-2 expression.
11979459 2002
×
Entrez Id: 1380
Gene Symbol: CR2
CR2
0.100
AlteredExpression
group
LHGDN
These results suggest the possible modulation of EBV infection via thiol-dependent redox control of CD21 , and thiol-antioxidants may be good candidates for controlling EBV infection .
11813981 2001
×
Entrez Id: 960
Gene Symbol: CD44
CD44
0.040
Biomarker
group
LHGDN
These results suggest that TIMP1 functions as a differentiating and survival factor of GC B cells by modulating CD44 and SHP1 in the late centrocyte/post-GC stage, regardless of EBV infection .
18502033 2008
×
Entrez Id: 5777
Gene Symbol: PTPN6
PTPN6
0.020
Biomarker
group
LHGDN
These results suggest that TIMP1 functions as a differentiating and survival factor of GC B cells by modulating CD44 and SHP1 in the late centrocyte/post-GC stage, regardless of EBV infection .
18502033 2008
×
Entrez Id: 1612
Gene Symbol: DAPK1
DAPK1
0.020
PosttranslationalModification
group
LHGDN
Evaluation of DAPK gene methylation and HPV and EBV infection in cervical cells from patients with normal cytology and colposcopy.
18026971 2008
×
Entrez Id: 5743
Gene Symbol: PTGS2
PTGS2
0.020
AlteredExpression
group
LHGDN
In this report we show that Nm23-H1 and EBNA3C can modulate expression of COX-2 in the context of EBV infection and transformation.
16415009 2006
×
Entrez Id: 1880
Gene Symbol: GPR183
GPR183
0.020
AlteredExpression
group
LHGDN
Based on the constitutive signaling and cellular expression pattern of EBI2 , it is suggested that it may function in conjunction with BILF1 in the reprogramming of the cell during EBV infection .
16540462 2006
×
Entrez Id: 2633
Gene Symbol: GBP1
GBP1
0.010
AlteredExpression
group
LHGDN
Oligonucleotide microarray analysis of gene expression profiles followed by real-time reverse-transcriptase polymerase chain reaction assay in chronic active Epstein-Barr virus infection.
18260761 2008